Vitelliform macular dystrophy 2: genes and variants
Explore variant evidence for Vitelliform macular dystrophy 2 across 2 analyzed proteins (BEST1, PRPH2). Linked ClinVar records include 42 pathogenic or likely pathogenic variants, 21 variants of uncertain significance and 10 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Vitelliform macular dystrophy 2
BEST1: Bestrophin-1
It helps regulate ion transport and fluid homeostasis across the retinal pigment epithelium. Pathogenic variants cause bestrophinopathies including Best vitelliform macular dystrophy, autosomal recessive bestrophinopathy, and some retinitis pigmentosa phenotypes.
39 ClinVar pathogenic / likely pathogenic and 25 uncertain variants in BEST1 have source records linked to Vitelliform macular dystrophy 2. Association strength is not clinical gene validity.
PRPH2: Peripherin-2
It organizes and stabilizes the rim structure of photoreceptor outer-segment discs. Pathogenic variants cause a wide range of inherited retinal diseases including retinitis pigmentosa, pattern dystrophy, and macular dystrophy.
3 ClinVar pathogenic / likely pathogenic and 6 uncertain variants in PRPH2 have source records linked to Vitelliform macular dystrophy 2. Association strength is not clinical gene validity.
Where Vitelliform macular dystrophy 2 variants cluster
- BEST1 Cytoplasmic (positions 1–31): 11 of 38 ClinVar pathogenic / likely pathogenic variants, 5.5× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Vitelliform macular dystrophy 2
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| BEST1 R218C | 218 | Cytoplasmic | Pathogenic / likely pathogenic (★★★★) |
| BEST1 A243V | 243 | Transmembrane | Pathogenic / likely pathogenic (★★★★) |
| BEST1 T6K | 6 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| BEST1 R218S | 218 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| BEST1 T6A | 6 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| BEST1 R218H | 218 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| BEST1 L21V | 21 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| BEST1 S27G | 27 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| BEST1 Y29C | 29 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| BEST1 K30R | 30 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| BEST1 W93C | 93 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| BEST1 E98G | 98 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| BEST1 T237S | 237 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| BEST1 I295T | 295 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| BEST1 F305L | 305 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| BEST1 W24C | 24 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| BEST1 R25W | 25 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| BEST1 P101L | 101 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| BEST1 R255W | 255 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| BEST1 E300D | 300 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| BEST1 V311G | 311 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| BEST1 R47H | 47 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| PRPH2 R172Q | 172 | Lumenal | Pathogenic / likely pathogenic (★★) |
| BEST1 V9G | 9 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| BEST1 R122W | 122 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| BEST1 D301H | 301 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| BEST1 D303Y | 303 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| BEST1 N95Y | 95 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| BEST1 Q58E | 58 | Extracellular | Pathogenic / likely pathogenic (★) |
| BEST1 N190K | 190 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| BEST1 S246N | 246 | Transmembrane | Pathogenic / likely pathogenic (★) |
| BEST1 Y284F | 284 | Transmembrane | Pathogenic / likely pathogenic (★) |
| BEST1 E292Q | 292 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| BEST1 L75F | 75 | Transmembrane | Pathogenic / likely pathogenic (★) |
| BEST1 N296K | 296 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| PRPH2 I177S | 177 | Lumenal | Pathogenic / likely pathogenic (★) |
| PRPH2 W246R | 246 | Lumenal | Pathogenic / likely pathogenic (★) |
| BEST1 T6P | 6 | Cytoplasmic | Pathogenic / likely pathogenic |
| BEST1 N99H | 99 | Cytoplasmic | Pathogenic / likely pathogenic |
| BEST1 D302N | 302 | Cytoplasmic | Pathogenic / likely pathogenic |
| BEST1 D304N | 304 | Cytoplasmic | Pathogenic / likely pathogenic |
| BEST1 L20V | 20 | Cytoplasmic | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Vitelliform macular dystrophy 2
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| BEST1 Y284C | 284 | Transmembrane | Conflicting reports (★) | +7: Y284F at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.980 |
Which prediction tools work for Vitelliform macular dystrophy 2
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MetaSVM: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 88 out of 100
- SIFT: 87 out of 100
- phyloP: 84 out of 100
- SpliceAI: 68 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 21 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Autosomal recessive bestrophinopathy also has ClinVar records linked to BEST1 variants; they fall mostly in different places as the Vitelliform macular dystrophy 2 variants (22 pathogenic / likely pathogenic).
- Autosomal dominant vitreoretinochoroidopathy also has ClinVar records linked to BEST1 variants; they fall mostly in different places as the Vitelliform macular dystrophy 2 variants (9 pathogenic / likely pathogenic).
- Retinal disorder also has ClinVar records linked to BEST1 variants; they fall in the same places as the Vitelliform macular dystrophy 2 variants (4 pathogenic / likely pathogenic).
- BEST1-related dominant retinopathy also has ClinVar records linked to BEST1 variants; they fall mostly in different places as the Vitelliform macular dystrophy 2 variants (3 pathogenic / likely pathogenic).
- Retinitis pigmentosa also has ClinVar records linked to PRPH2 variants; they fall partly in the same places as the Vitelliform macular dystrophy 2 variants (14 pathogenic / likely pathogenic).
- Patterned dystrophy of the retinal pigment epithelium also has ClinVar records linked to PRPH2 variants; they fall mostly in different places as the Vitelliform macular dystrophy 2 variants (11 pathogenic / likely pathogenic).
- Stargardt disease also has ClinVar records linked to PRPH2 variants; they fall mostly in different places as the Vitelliform macular dystrophy 2 variants (4 pathogenic / likely pathogenic).
- Fundus albipunctatus also has ClinVar records linked to PRPH2 variants; they fall mostly in different places as the Vitelliform macular dystrophy 2 variants (3 pathogenic / likely pathogenic).
- Patterned macular dystrophy also has ClinVar records linked to PRPH2 variants; they fall mostly in different places as the Vitelliform macular dystrophy 2 variants (3 pathogenic / likely pathogenic).
Diseases related to Vitelliform macular dystrophy 2
- Retinitis pigmentosa, also linked to BEST1 and PRPH2
- Retinal disorder, also linked to BEST1 and PRPH2
- Cone-rod dystrophy, also linked to PRPH2
- Stargardt disease, also linked to PRPH2
- Autosomal recessive bestrophinopathy, also linked to BEST1
- Patterned dystrophy of the retinal pigment epithelium, also linked to PRPH2
- Autosomal dominant vitreoretinochoroidopathy, also linked to BEST1
- Fundus albipunctatus, also linked to PRPH2
- Isolated macular dystrophy, also linked to BEST1
- Patterned macular dystrophy, also linked to PRPH2
- BEST1-related dominant retinopathy, also linked to BEST1
- Choroidal dystrophy, central areolar, also linked to PRPH2
Frequently asked questions
Which genes have records linked to Vitelliform macular dystrophy 2?
This view contains 2 analyzed proteins: BEST1, PRPH2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 42 pathogenic or likely pathogenic variants, 21 variants of uncertain significance and 10 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 164 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center